Covered recipient · General Payments record
LAKSHMI L MARELLA
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2021–2025
$786.56
- Reported across 41 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $265.04 | 12 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $49.53 | 2 |
| Lilly USA, LLC | $40.65 | 2 |
| Acerta Pharma LLC | $40.02 | 2 |
| Novo Nordisk AS | $39.60 | 2 |
| ABBVIE INC. | $28.20 | 1 |
| E.R. Squibb & Sons, L.L.C. | $24.13 | 1 |
| Esperion Therapeutics, Inc. | $21.58 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $21.33 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $28.20 | 03/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203017754 | CMS |
| Amgen Inc. | $21.10 | 03/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228471846 | CMS |
| Amgen Inc. | $28.43 | 04/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228471844 | CMS |
| AstraZeneca Pharmaceuticals LP | $21.31 | 09/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1206713545 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.71 | 10/29/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1206415151 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $21.33 | 03/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1225639273 | CMS |
| E.R. Squibb & Sons, L.L.C. | $24.13 | 02/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1184562017 | CMS |
| Esperion Therapeutics, Inc. | $21.58 | 02/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1243967308 | CMS |
| Lilly USA, LLC | $22.42 | 05/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186741921 | CMS |
| Lilly USA, LLC | $18.23 | 08/19/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186705851 | CMS |
| Novo Nordisk Inc | $19.75 | 08/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188810119 | CMS |
| Novo Nordisk Inc | $19.85 | 08/26/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188209036 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2021, 2022, 2023, 2024, 2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.